Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice : A propensity-matched analysis of 76,940 patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice ; volume:117 ; number:06 ; year:2017 ; pages:1072-1082
Thrombosis and haemostasis ; 117, Heft 06 (2017), 1072-1082
- Beteiligte Personen und Organisationen
-
Li, Xiaoyan
Deitelzweig, Steve
Keshishian, Allison
Hamilton, Melissa
Horblyuk, Ruslan
Gupta, Kiran
Luo, Xuemei
Mardekian, Jack
Friend, Keith
Nadkarni, Anagha
Pan, Xianying
Lip, Gregory Y. H.
- DOI
-
10.1160/TH17-01-0068
- URN
-
urn:nbn:de:101:1-2019041408371805575047
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Xiaoyan
- Deitelzweig, Steve
- Keshishian, Allison
- Hamilton, Melissa
- Horblyuk, Ruslan
- Gupta, Kiran
- Luo, Xuemei
- Mardekian, Jack
- Friend, Keith
- Nadkarni, Anagha
- Pan, Xianying
- Lip, Gregory Y. H.
Ähnliche Objekte (12)
Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
MicroRNA profiling in the left atrium in patients with non-valvular paroxysmal atrial fibrillation
Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design
Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
MicroRNA profiling in the left atrium in patients with non-valvular paroxysmal atrial fibrillation
Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design
Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
MicroRNA profiling in the left atrium in patients with non-valvular paroxysmal atrial fibrillation